|
Press Releases |
|
|
|
Friday, April 3, 2020 |
|
아방스 클리니컬, APAC 바이오테크 고객사들이 임상시험을 위해 호주를 선택하는 주요 이유 밝혀 |
호주의 임상시험수탁기관(CRO)인 아방스 클리니컬(Avance Clinical)은 클라이언트 온보딩 피드백을 토대로 APAC 바이오테크 기업들이 초기 임상시험을 위해 호주를 선택하는 주요 이유를 오늘 밝혔다. more info >> |
|
Thursday, April 2, 2020 |
|
Avance Clinical on Top Reasons APAC Biotech Clients Choose Australia for Clinical Trials |
Leading Australian CRO Avance Clinical today detailed the top reasons its APAC biotechs selected Australia for their early phase clinical trials, based on client onboarding feedback. more info >> |
|
Friday, March 20, 2020 |
|
澳大利亞CRO, Avance Clinical公司在COVID-19疫苗和臨床試驗治療方案方面具有得天獨厚的優勢 |
澳大利亞CRO Avance Clinical今天表示,澳大利亞快速的監管審批環境,關鍵意見領袖的專業知識和高質量的臨床研究中心,以及頗具吸引力的40%的政府臨床試驗支出退稅,所有這一切都意味著Avance具有得天獨厚的優勢,能夠使緊迫的COVID-19試驗速見成效。 more info >> |
|
澳大利亚CRO, Avance Clinical公司在COVID-19疫苗和临床试验治疗方案方面具有得天独厚的优势 |
澳大利亚CRO Avance Clinical今天表示,澳大利亚快速的监管审批环境,关键意见领袖的专业知识和高质量的临床研究中心,以及颇具吸引力的40%的政府临床试验支出退税,所有这一切都意味着Avance具有得天独厚的优势,能够使紧迫的COVID-19试验速见成效。 more info >> |
|
호주 임상시험수탁기관인 아방스 클리니컬, COVID-19 백신 및 치료제 개발을 위한 임상시험에 독보적 위치 점유 |
호주의 임상시험수탁기관(CRO)인 아방스 클리니컬(Avance Clinical)은 호주의 빠른 규제 승인 환경과 주요 오피니언 리더들의 전문성, 고품질 임상 연구소 및 임상시험 지출에 대해 정부가 지급하는 40%의 보조금 등으로 인해 자신들이 COVID-19 관련 임상시험에서 신속히 결과를 낼 수 있는 유리한 위치에 있다고 오늘 밝혔다. more info >> |
|
Australian CRO, Avance Clinical is Uniquely Positioned for COVID-19 Vaccines and Therapies Clinical Trials |
Australian CRO Avance Clinical said today that Australia's fast regulatory approval environment, key opinion leader expertise and high-quality clinical research sites, as well as the attractive 40% Government rebate on clinical trial spend, means Avance is uniquely positioned to deliver rapid results for urgent COVID-19 trials. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
侨雄国际宣布委任段玉聪院士为人工智能实验室首席科学家
Nov 5, 2024 19:25 HKT/SGT
|
|
|
华邦科技正式更名为「亨利加集团有限公司」
Nov 5, 2024 19:15 HKT/SGT
|
|
|
華邦科技正式更名為「亨利加集團有限公司」
Nov 5, 2024 19:11 HKT/SGT
|
|
|
僑雄國際宣佈委任段玉聰院士為人工智能實驗室首席科學家
Nov 5, 2024 19:00 HKT/SGT
|
|
|
ALMAC to open mid-November
Nov 5, 2024 18:46 HKT/SGT
|
|
|
Champion REIT Recognised as 'GRESB Global Listed Sector Leader'
Nov 5, 2024 18:11 HKT/SGT
|
|
|
富士通、東証の株式売買システム「arrowhead4.0」を運用開始
Nov 5, 2024 18:00: JST
|
|
|
冠君产业信托获GRESB评为「全球业界领导者(上市企业)」
Nov 5, 2024 17:41 HKT/SGT
|
|
|
冠君產業信託獲GRESB評為「全球業界領導者(上市企業)」
Nov 5, 2024 17:14 HKT/SGT
|
|
|
Victory and world title for TOYOTA GAZOO Racing
Nov 5, 2024 17:59 JST
|
|
|
Tokyo Stock Exchange and Fujitsu announce renewal of cash equity trading system 'arrowhead4.0'
Nov 5, 2024 17:13 JST
|
|
|
Mitsubishi Heavy Industries Continues Order Intake, Revenue, and Profit Growth in Strong First Half, Raises Full-Year Order Intake Guidance
Nov 5, 2024 14:37 JST
|
|
|
Interroyal Engineering PCL (SET: IROYAL) Posts Strong Showing on First Trading Day
Nov 5, 2024 13:00 HKT/SGT
|
|
|
華泰證券入圍「跨境理財通」試點 服務大灣區多元化財富管理需求
Nov 5, 2024 11:50 HKT/SGT
|
|
|
Eisai's Corporate Venture Capital Subsidiary, Eisai Innovation, Inc., Selected for AMED's 'Strengthening Program for Pharmaceutical Startup Ecosystem"
Nov 5, 2024 11:35 JST
|
|
|
|
More News >> |
|
|
|
|
|